Podcast


Presenter: Dr Carmen Johnson MD CFPC FCFPC CAC Palliative Medicine FASAM ABFP

Podcast: FM Rounds #6: Delirium at End of Life: The Dying Brain
0:00

New research has improved new insights into the pathophysiology of neurotransmitter derangement in the delirious brain.  Hear how these derangements contribute to the morbidity and mortality of delirium.  Patient and caregiver experiences are also discussed. Learning objectives: Explore new insights in the delirium experience Examine Neurotransmitter derangement in the delirious brain Identify clinical screening questions…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
Download this lecture attachments:
MIGS-Delirium-2022-Final.pdf



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #32: Pediatric Asthma

In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Brea Salter, a 4-year old girl presenting with wheezing. To earn an additional 0.25…
Listen 0.5 credits available

BS Medicine Episode #592: Pharm for Fibro: Can antidepressants ease the pain?

In episode 592, Mike and James invite Jennifer Young back to the podcast to review the evidence around the use of antidepressants in the challenging pain condition of fibromyalgia. We…
Listen 0.5 credits available

BS Medicine Episode #591: Testosterone supplementation for cis-gender men

In episode 591, Mike and James invite Samantha Moe back to the podcast to review the evidence for using testosterone in older men. We talk about the impact testosterone supplementation…
Listen 0.5 credits available

Presenter(s):

Dr Carmen Johnson MD CFPC FCFPC CAC Palliative Medicine FASAM ABFP

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr Carmen Johnson MD CFPC FCFPC CAC Palliative Medicine FASAM ABFP

Spearkers do not have any conflicts of interest to declare.